PW
Paul Wachter
Director

Paul Wachter insider trades: Avalanche Biotechnologies stock buys and sales

Director, Avalanche Biotechnologies Last trade Jun 15, 2015 44 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
14
Open-market trades
since 2010
4
Companies
last trade 2015

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Paul reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 15, 2015[AAVL]↓ Sell$48K
Jun 8, 2015[AAVL]↓ Sell$46K
Jun 1, 2015[AAVL]↓ Sell$43K
May 26, 2015[AAVL]↓ Sell$44K
May 18, 2015[AAVL]↓ Sell$42K
May 11, 2015[AAVL]↓ Sell$40K
May 4, 2015AAVL↓ Sell$37K
Apr 27, 2015AAVL↓ Sell$42K
Apr 20, 2015AAVL↓ Sell$48K
Apr 13, 2015AAVL↓ Sell$47K
Jan 13, 2015AAVL↓ Sell$776K
Nov 12, 2014TWX↑ Buy$389K
Aug 9, 2013TWX↑ Buy$193K
Dec 15, 2010TWX↑ Buy$94K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Paul Wachter's insider trades

Paul Wachter is a director at Avalanche Biotechnologies. Since Dec 15, 2010, Paul has reported 3 open-market purchases worth $677K and 11 sales worth $1.2M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (19 filings), option exercises (8 filings), shares returned to the company (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.